Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Mar-24 7:28 PM View:  | An2 Therapeutics, Inc. (ANTX) | 15-Mar-24 | Grant | 30,000 | -- | -- | 1567% 1.91K to 31.91K | |
| 11-Jan-24 7:59 PM View: | An2 Therapeutics, Inc. (ANTX) | 09-Jan-24 | Option Exercise | 7,417 | $4.59 | $34,015.10 | 388% 1.91K to 9.33K | |
| 11-Jan-24 7:59 PM View: | An2 Therapeutics, Inc. (ANTX) | 09-Jan-24 | Planned Option Sale | 7,417 | $20.14 | $149,367.00 | (79%) 9.33K to 1.91K | |
| 04-Jan-24 6:06 PM View: | An2 Therapeutics, Inc. (ANTX) | 02-Jan-24 | Option Exercise | 2,583 | $0.42 | $1,084.86 | 135% 1.91K to 4.5K | |
| 04-Jan-24 6:06 PM View: | An2 Therapeutics, Inc. (ANTX) | 02-Jan-24 | Planned Option Sale | 2,583 | $20.12 | $51,967.10 | (57%) 4.5K to 1.91K |